{"name": "Onconova Therapeutics",
 "permalink": "onconova-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/onconova-therapeutics",
 "homepage_url": "http://www.onconova.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1998,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "267-759-3680",
 "description": "A private biopharmaceutical company ",
 "created_at": "Wed Aug 15 05:20:39 UTC 2012",
 "updated_at": "Fri May 03 10:41:48 UTC 2013",
 "overview": "\u003Cp\u003EOnconova Therapeutics is a private biopharmaceutical company providing innovative solutions for treating cancer and combating radiation injury. The company currently has one Phase III clinical-stage compound, two Phase I products in clinical development, and more than a half-dozen, well-differentiated preclinical compounds. The most advanced product, rigosertib (Estybon\u00ae, ON 01910.Na), is now in a pivotal trial being conducted under a Special Protocol Assessment (SPA) from the United States FDA for myelodysplastic syndrome (MDS), as well as in a Phase II trial for ovarian cancer and a Phase II/III trial for pancreatic cancer.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       35],
      "assets/images/resized/0020/6140/206140v2-max-150x150.jpg"],
     [[250,
       58],
      "assets/images/resized/0020/6140/206140v2-max-250x250.jpg"],
     [[304,
       71],
      "assets/images/resized/0020/6140/206140v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President , CEO  \u0026 Board of Directors",
    "person":
     {"first_name": "Ramesh",
      "last_name": "Kumar",
      "permalink": "ramesh-kumar",
      "image": null}},
   {"is_past": false,
    "title": "Chief Medical Officer \u0026 Senior Vice President",
    "person":
     {"first_name": "Francois",
      "last_name": "E. Wilhelm",
      "permalink": "francois-e-wilhelm",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Ajay",
      "last_name": "Bansal",
      "permalink": "ajay-bansal-7",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice-President, Commercial",
    "person":
     {"first_name": "Scott",
      "last_name": "T. Megaffin",
      "permalink": "scott-t-megaffin",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President, Finance \u0026 Corporate Development",
    "person":
     {"first_name": "James",
      "last_name": "R. Altland",
      "permalink": "james-r-altland",
      "image": null}},
   {"is_past": false,
    "title": "President, Research and Development",
    "person":
     {"first_name": "Thomas",
      "last_name": "J. McKearn",
      "permalink": "thomas-j-mckearn",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice-President, Quality Management",
    "person":
     {"first_name": "Dave",
      "last_name": "Stephon",
      "permalink": "dave-stephon",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Henry",
      "last_name": "S. Bienen",
      "permalink": "henry-s-bienen",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Viren",
      "last_name": "Mehta",
      "permalink": "viren-mehta",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "K.",
      "last_name": "Ravindra",
      "permalink": "k-ravindra",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Alan",
      "last_name": "R. Williamson",
      "permalink": "alan-r-williamson",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President, Product Development",
    "person":
     {"first_name": "Manoj",
      "last_name": "Maniar",
      "permalink": "manoj-maniar",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Michael",
      "last_name": "B. Hoffman",
      "permalink": "michael-b-hoffman",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Chandra",
      "last_name": "Shekhar Reddy Kundur",
      "permalink": "chandra-shekhar-reddy-kundur",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Pankaj",
      "last_name": "R. Patel",
      "permalink": "pankaj-r-patel",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors \u0026 Founded",
    "person":
     {"first_name": "E.",
      "last_name": "Premkumar Reddy",
      "permalink": "e-premkumar-reddy",
      "image": null}},
   {"is_past": true,
    "title": "Controller",
    "person":
     {"first_name": "Kimberly",
      "last_name": "Glacken Reif",
      "permalink": "kimberly-glacken-reif",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$50M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/onconova-hauls-50m-fuel-late-stage-leukemia-program/2012-08-14?utm_source=rss\u0026utm_medium=rss",
    "source_description": "Onconova hauls in $50M to fuel late-stage leukemia program",
    "raised_amount": 50000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 8,
    "funded_day": 14,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "375 Pheasant Run",
    "address2": "",
    "zip_code": "18940",
    "city": "Newtown",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": " Onconova Lands $565M Deal with Baxter, Looks Ahead to Possible Regulatory Filing ",
    "stoned_year": 2012,
    "stoned_month": 9,
    "stoned_day": 20,
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020120920e89ktstno\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120920e89ktstno%26from%3dalert%26pid%3d32",
    "source_text": "",
    "source_description": " Onconova Lands $565M Deal with Baxter, Looks Ahead to Possible Regulatory Filing ",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Onconova Therapeutics",
      "permalink": "onconova-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        128],
       "assets/images/resized/0020/6141/206141v1-max-150x150.jpg"],
      [[250,
        214],
       "assets/images/resized/0020/6141/206141v1-max-250x250.jpg"],
      [[450,
        385],
       "assets/images/resized/0020/6141/206141v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}